Talphera (TLPH) closed at $0.86 on November 16, 2026, down 5.0% from the previous close, on volume of 322,695 shares (30-day average 143,672).
Data as of November 16, 2026.
16-Nov-2026
Talphera Earnings Call Highlights Niyad’s Growth Potential
TipRanks (Sat, 14-Nov 11:47 PM ET)
Talphera’s Niyad Advances Toward Potential 2027 FDA Approval as Phase 3 Trial Nears Completion
TipRanks (Sat, 14-Nov 11:35 AM ET)
Analysts Offer Insights on Healthcare Companies: Talphera (TLPH) and Ibio (IBIO)
TipRanks (Fri, 13-Nov 9:20 AM ET)
Talphera GAAP EPS of -$0.05 beats by $0.01
Seeking Alpha News (Thu, 12-Nov 4:19 PM ET)
Talphera Reports Third Quarter 2026 Financial Results and Provides Business Update
PRNewswire (Thu, 12-Nov 4:01 PM ET)
Here are the major earnings after the close Thursday
Seeking Alpha News (Thu, 12-Nov 10:00 AM ET)
Talphera to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026
PRNewswire (Wed, 4-Nov 8:30 AM ET)
Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
PRNewswire (Thu, 3-Sep 8:30 AM ET)
Talphera (TLPH) Jumps 36.61% After $5 Million CorMedix Investment—Phase 3 Study in Focus
Market Chameleon (Mon, 8-Sep 7:00 AM ET)
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Talphera trades on the NASDAQ stock market under the symbol TLPH.
As of November 16, 2026, TLPH stock price declined to $0.86 with 322,695 million shares trading.
TLPH has a beta of 0.97, meaning it tends to be less sensitive to market movements. TLPH has a correlation of 0.04 to the broad based SPY ETF.
TLPH has a market cap of $44.73 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that TLPH belongs to (by Net Assets): VXF, VTI.
TLPH has underperformed the market in the last year with a price return of -18.0% while the SPY ETF gained +11.2%. TLPH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -28.9% and -16.4%, respectively, while the SPY returned -4.6% and -2.1%, respectively.
TLPH support price is $.87 and resistance is $.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TLPH shares will trade within this expected range on the day.